PIZZUTI, Laura
 Distribuzione geografica
Continente #
NA - Nord America 1.179
EU - Europa 420
AS - Asia 62
AF - Africa 16
SA - Sud America 7
OC - Oceania 2
Totale 1.686
Nazione #
US - Stati Uniti d'America 1.152
IT - Italia 189
FR - Francia 99
DE - Germania 55
CA - Canada 27
IN - India 19
CN - Cina 16
GB - Regno Unito 14
ZA - Sudafrica 13
NL - Olanda 11
FI - Finlandia 9
KR - Corea 8
CH - Svizzera 6
SE - Svezia 6
UA - Ucraina 6
AE - Emirati Arabi Uniti 5
ES - Italia 5
CL - Cile 4
RU - Federazione Russa 4
GR - Grecia 3
ID - Indonesia 3
SA - Arabia Saudita 3
BE - Belgio 2
CZ - Repubblica Ceca 2
PE - Perù 2
PH - Filippine 2
PL - Polonia 2
AU - Australia 1
BG - Bulgaria 1
BR - Brasile 1
CI - Costa d'Avorio 1
EG - Egitto 1
GH - Ghana 1
HK - Hong Kong 1
JO - Giordania 1
JP - Giappone 1
LT - Lituania 1
LV - Lettonia 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PT - Portogallo 1
RO - Romania 1
SI - Slovenia 1
TR - Turchia 1
TW - Taiwan 1
Totale 1.686
Città #
Santa Cruz 132
Fairfield 107
Rome 93
Ashburn 92
Seattle 90
Buffalo 75
Houston 64
Woodbridge 59
Wilmington 48
Cambridge 44
Chicago 22
Ann Arbor 21
Des Moines 19
Boardman 17
Columbus 15
Bremen 13
Los Angeles 12
Clearwater 11
Muizenberg 11
Ottawa 11
Paris 10
Dallas 9
Phoenix 9
San Diego 9
Toronto 9
Helsinki 8
Milan 8
Las Vegas 6
Stockholm 6
Amsterdam 5
Aviano 5
Bad Kreuznach 5
Büdelsdorf 5
New York 5
San Jose 5
Andover 4
Cedar Knolls 4
Mumbai 4
Riva 4
San Francisco 4
Seoul 4
Wuhan 4
Council Bluffs 3
Frankfurt am Main 3
Gibsons 3
Guangzhou 3
Gunzenhausen 3
London 3
New Delhi 3
Rende 3
Reston 3
Yellow Springs 3
Barcelona 2
Bathinda 2
Burgos 2
Falkenstein 2
Fiumicino 2
Fleming Island 2
Fort Myers 2
Frankfurt Am Main 2
Genoa 2
Henderson 2
Ipswich 2
Jacksonville 2
Lake Forest 2
Malo 2
Miami 2
Milton 2
Mountain View 2
Nutley 2
Oude Meer 2
Padova 2
Pietra Ligure 2
Pune 2
San Mateo 2
Santiago 2
Scranton 2
Shenyang 2
Warsaw 2
A Coruña 1
Abidjan 1
Amman 1
Aprilia 1
Atherstone 1
Atlanta 1
Auckland 1
Augusta 1
Austin 1
Avigliano 1
Bad Bramstedt 1
Baotou 1
Bari 1
Beijing 1
Bergamo 1
Birmingham 1
Bisceglie 1
Bologna 1
Boulder 1
Boydton 1
Brescia 1
Totale 1.193
Nome #
Metabolic determinants and anthropometric indicators impact clinical-pathological features in epithelial ovarian cancer patients, file e3835315-c032-15e8-e053-a505fe0a3de9 128
The impact of locoregional treatment on response to Nivolumab in advanced platinum refractory head and neck cancer: the NEED TRIAL, file e3835325-4ef0-15e8-e053-a505fe0a3de9 126
Immunotherapy in HER2-positive breast cancer. state of the art and future perspectives, file e3835326-cb79-15e8-e053-a505fe0a3de9 115
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study, file e3835321-b842-15e8-e053-a505fe0a3de9 110
Fasting glucose and body mass index as predictors of activity in breast cancer patients treated with everolimus-exemestane: the EverExt study, file e3835323-6a17-15e8-e053-a505fe0a3de9 102
Observational study of coagulation activation in early breast cancer: development of a prognostic model based on data from the real world setting, file e3835323-1887-15e8-e053-a505fe0a3de9 95
Autoantibodies specific to ERa are involved in tamoxifen resistance in hormone receptor positive breast cancer, file e3835324-0148-15e8-e053-a505fe0a3de9 93
A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab, file e3835322-fdd0-15e8-e053-a505fe0a3de9 90
Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab, file e3835323-37d4-15e8-e053-a505fe0a3de9 90
Role of chemotherapy in vulvar cancers: time to rethink standard of care?, file e383532d-39c4-15e8-e053-a505fe0a3de9 86
The sexist behaviour of immune checkpoint inhibitors in cancer therapy?, file e3835323-4c50-15e8-e053-a505fe0a3de9 82
Biomarkers of response and resistance to CDK4/6 inhibitors in breast cancer: hints from liquid biopsy and microRNA exploration, file 44358de5-5bd3-471b-af6e-a66928cf6783 79
"Triple positive" early breast cancer: an observational multicenter retrospective analysis of outcome, file e3835321-f215-15e8-e053-a505fe0a3de9 76
Cdk4/6 inhibitor treatments in patients with hormone receptor positive, her2 negative advanced breast cancer. Potential molecular mechanisms, clinical implications and future perspectives, file e383532a-18d9-15e8-e053-a505fe0a3de9 75
Long-Term Safety and Real-World Effectiveness of Trastuzumab in Breast Cancer, file e3835322-acbf-15e8-e053-a505fe0a3de9 64
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting, file e3835322-d440-15e8-e053-a505fe0a3de9 59
Neoadjuvant immune-checkpoint blockade in triple-negative breast cancer: current evidence and literature-based meta-analysis of randomized trials, file e383532b-35b3-15e8-e053-a505fe0a3de9 57
Efficacy of immunotherapy in lung cancer with co-occurring mutations in NOTCH and homologous repair genes, file e3835328-2476-15e8-e053-a505fe0a3de9 46
Observational multicenter study on the prognostic relevance of coagulation activation in risk assessment and stratification in locally advanced breast cancer. Outline of the arias trial, file e383532d-1991-15e8-e053-a505fe0a3de9 40
COVID-19 risk in breast cancer patients receiving CDK4/6 inhibitors: literature data and a monocentric experience, file 45f6d0d2-c79f-4c8b-a254-29e4d8fe77a0 33
The Role of the CDK4/6 Inhibitor Ribociclib in Locally Advanced and Oligometastatic Hormone Receptor Positive, Her2 Negative, Advanced Breast Cancer: Case Series and Review of the Literature, file e383532e-d595-15e8-e053-a505fe0a3de9 22
Neoadjuvant endocrine therapy in breast cancer. Current knowledge and future perspectives, file e383532e-e0a7-15e8-e053-a505fe0a3de9 18
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting, file e383532e-fa2b-15e8-e053-a505fe0a3de9 15
Circulating hpv dna in the management of oropharyngeal and cervical cancers: current knowledge and future perspectives, file 28d040f3-75f0-4669-9847-0444212b96d4 12
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial, file 414ca0a4-8e30-4a18-94ef-25ad85b00f14 11
MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study, file a4d4c711-927f-4aaf-9908-49639ba20321 10
null, file e5e1a280-5390-4e9c-a00f-60b5a538c9cc 9
Safety analysis, association with response and previous treatments of everolimus and exemestane in 181 metastatic breast cancer patients. A multicenter Italian experience, file e3835321-705d-15e8-e053-a505fe0a3de9 8
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting, file e383532a-6618-15e8-e053-a505fe0a3de9 8
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence, file e3835324-d18f-15e8-e053-a505fe0a3de9 6
KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden, file e3835329-7ad4-15e8-e053-a505fe0a3de9 5
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B, file 05958f16-baa4-4a32-b582-921681b22c71 4
Risk of SARS-CoV-2 infection and disease in metastatic triple-negative breast cancer patients treated with immune checkpoint inhibitors, file 5c52434d-69f0-4045-aa86-68e5004acaa2 4
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience, file e383531d-6cf8-15e8-e053-a505fe0a3de9 4
Burnout of health care providers during the covid-19 pandemic: Focus on medical oncologists, file e383532f-2e8a-15e8-e053-a505fe0a3de9 2
Neoadjuvant sequential docetaxel followed by high-dose epirubicin in combination with cyclophosphamide administered concurrently with trastuzumab. The DECT trial, file e3835315-7bd4-15e8-e053-a505fe0a3de9 1
Non-pegylated liposomal doxorubicin-cyclophosphamide in sequential regimens with taxanes as neoadjuvant chemotherapy in breast cancer patients, file e3835315-dd08-15e8-e053-a505fe0a3de9 1
KEAP1 and TP53 frame genomic, evolutionary and immunological subtypes of lung adenocarcinoma with different sensitivity to immunotherapy, file e383532d-1993-15e8-e053-a505fe0a3de9 1
Totale 1.787
Categoria #
all - tutte 4.034
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.034


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201923 0 0 0 0 0 0 0 0 0 0 8 15
2019/2020275 4 4 11 10 33 26 39 35 40 27 24 22
2020/2021341 25 18 18 25 8 29 21 20 36 90 33 18
2021/2022424 22 22 33 22 48 17 19 22 22 18 125 54
2022/2023406 33 12 102 77 24 42 21 12 4 35 39 5
2023/2024305 16 20 31 26 54 39 35 50 9 11 14 0
Totale 1.787